← Look up another company

What a buyer sees

CHEMIDEX PHARMA LIMITED

Manufacture of basic pharmaceutical products · Egham · 01676110

33staff · FY2022
44years trading
58oldest owner on file
£8.2Mcash at bank

Your turnover is on public record

filed
£31Mfor the year to 2022

Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.

How you sit in your trade

slowest tenth typical fastest tenth you
Sales per employee£929,742above almost all
£929,742
£75,818£268,200£906,093
Debtor daysdays77in the top quarter
77
225592
Creditor daysdays5
5
113064
Stock daysdays25in the middle half
25
1049126

Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.

What a buyer would ask 3

  • The newest accounts on file are 50 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
  • Debtor days run high for your tradeYours is 77 against 55 for the middle of 905 comparable companies. That gap is working capital a buyer has to fund on day one, and it comes off the price.
  • No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.

What a buyer would like 2

  • 44 years of trading on fileLongevity is the cheapest evidence there is that the business is not one contract.
  • Sales per employee better than three quarters of your tradeYours is 929,742 against 268,200 for the middle of 1,029 comparable companies.

What the register says

Owners

  • 58since 2019

Directors

No current directors loaded.

Accounts on public record
Year toTurnoverStaffCash
2022-06-30£31M33£8.2M

A rough bracket, and why it is only that

0.4–0.9× sales
£12M
£28M

The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.

Prepared by Qapital from public records, against 105,750 companies that did publish a turnover. No figure here was supplied by the company and none of it is advice. What it is missing is everything that actually sets a price: profitability, contracts, customer concentration, and whoever would run it next.

Tell us the rest

Your turnover is on file, but the things that set a price are not: margin, customer concentration, who would run it next. Tell us where you are and we will read it properly.

Goes to one inbox. No list, no sequence, and we will not pass it on. We buy companies as well as advise on them, so if yours is one we would be interested in, we will tell you that before anything else happens.